Systemic side effects of topical beta‐adrenergic blockers
WC Stewart, WP Castelli - Clinical Cardiology, 1996 - Wiley Online Library
Glaucoma, a disease that affects between 1 and 3% of the population above the age of 60,
is most commonly treated by topical beta‐adrenergic blockers. Although effective in lowering …
is most commonly treated by topical beta‐adrenergic blockers. Although effective in lowering …
Systemic side effects of topical beta-adrenergic blockers.
WC Stewart, WP Castelli - Clinical Cardiology, 1996 - europepmc.org
Glaucoma, a disease that affects between 1 and 3% of the population above the age of 60,
is most commonly treated by topical beta-adrenergic blockers. Although effective in lowering …
is most commonly treated by topical beta-adrenergic blockers. Although effective in lowering …
[引用][C] Systemic side effects of topical beta-adrenergic blockers
WC Stewart, WP Castelli - Clinical Cardiology, 1996 - cir.nii.ac.jp
Systemic side effects of topical beta-adrenergic blockers
WC Stewart, WP Castelli - Clinical cardiology, 1996 - pubmed.ncbi.nlm.nih.gov
Glaucoma, a disease that affects between 1 and 3% of the population above the age of 60,
is most commonly treated by topical beta-adrenergic blockers. Although effective in lowering …
is most commonly treated by topical beta-adrenergic blockers. Although effective in lowering …
[引用][C] Systemic side effects of topical beta-adrenergic blockers
WC STEWARD, WP CASTELLI - Clinical cardiology (Mahwah …, 1996 - pascal-francis.inist.fr
Systemic side effects of topical beta-adrenergic blockers CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …